Aptus Capital Advisors, LLC Astrazeneca PLC Transaction History
Aptus Capital Advisors, LLC
- $8.9 Billion
- Q4 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 6,342 shares of AZN stock, worth $466,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,342
Previous 2,606
143.36%
Holding current value
$466,644
Previous $203,000
104.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...